Cyteir Therapeutics Eulerpool naujienos

Cyteir Therapeutics Eulerpool News

Cyteir Therapeutics akcijų naujienos

Cyteir Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Cyteir Therapeutics naujienas mes pateikiame čia.

• kovo 7 d. ·

  Yahoo
  Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
• kovo 7 d. ·

  Thefly.com
  Cyteir Therapeutics announces timeline for voluntarily delisting from Nasdaq
• vasario 20 d. ·

  Business Wire
  Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
• sausio 5 d. ·

  Thefly.com
  Cyteir Therapeutics downgraded to Underperform at BofA, coverage terminated
• lapkričio 1 d. ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 20.00% to 3.06
• spalio 12 d. ·

  Yahoo
  Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile
• spalio 12 d. ·

  Thefly.com
  Cyteir: Cohort of CYT-0851 in combo for ovarian cancer well tolerated
• rugsėjo 18 d. ·

  SeekingAlpha
  Cyteir: Although The Company Is Winding Down, The Lead Asset Had Promise
• liepos 11 d. ·

  Fintel
  Fmr Now Owns 2.33% of Cyteir Therapeutics (CYT)
• liepos 6 d. ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 7.14% to 2.55